Policy Analysis: Shanghai’s 2025 Pharmaceutical Procurement Regulation and Market Implications
Shanghai’s Medical Centralized Bidding and Procurement Affairs Management Office has released its January 2025 list...
Shanghai’s Medical Centralized Bidding and Procurement Affairs Management Office has released its January 2025 list...
Shanghai’s Sunshine Medical Procurement All-In-One (SMPA) announced the suspension of procurement for indobufen, manufactured by...
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) platform has announced a significant policy shift regarding non-winning...
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has revealed that Hangzhou Singclean Medical Products Co., Ltd...
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) drug procurement platform has released a notice stating that...
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has released a document indicating that the city will...
The Shanghai Sunshine Medical Procurement All-in-One (SMPA) platform has revealed that it has suspended the...
In a departure from previous practice, the 7th national volume-based procurement (VBP) round will not...
China’s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related...